Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-022866
Filing Date
2025-05-07
Accepted
2025-05-07 07:08:22
Documents
69
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cccc-20250331.htm   iXBRL 10-Q 1280194
2 EX-31.1 cccc-20250331xexx311.htm EX-31.1 10366
3 EX-31.2 cccc-20250331xexx312.htm EX-31.2 10412
4 EX-32.1 cccc-20250331xexx321.htm EX-32.1 4743
5 EX-32.2 cccc-20250331xexx322.htm EX-32.2 4754
  Complete submission text file 0001628280-25-022866.txt   6073473

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20250331.xsd EX-101.SCH 42754
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cccc-20250331_cal.xml EX-101.CAL 66567
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cccc-20250331_def.xml EX-101.DEF 182834
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cccc-20250331_lab.xml EX-101.LAB 532366
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cccc-20250331_pre.xml EX-101.PRE 351610
72 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20250331_htm.xml XML 702989
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39567 | Film No.: 25919252
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)